Heart BMJ

JULY 10, 2024

Over the last few decades, treatment of severe AS has been revolutionised following the development of transcatheter aortic valve replacement (TAVR). Sarcopenia is an independent predictor of short-term and long-term outcomes after TAVR and should be incorporated as a prognostic marker in preprocedural planning.

Aortic valve 98

Aortic valve Aortic Quality of Life TAVR 98

Open Heart

FEBRUARY 27, 2024

Objectives The clinical outcomes of transcatheter aortic valve replacement (TAVR) in patients with aortic stenosis (AS) and concomitant active cancer remain insufficiently explored. This study aimed to assess the midterm outcomes of TAVR in patients diagnosed with AS and active cancer.

Aortic valve 98

Aortic valve Cancer Aortic TAVR 98

DAIC

JUNE 3, 2024

Morristown Medical Center’s Gagnon Cardiovascular Institute’s structural heart program recently reported it has reached a significant milestone of performing over 5,000 transcatheter aortic valve replacement (TAVR) procedures, the first in New Jersey and among the first to accomplish this in the United States.

TAVR 105

TAVR Aortic valve Aortic Hospital 105

DAIC

MARCH 14, 2025

Washington Convention Center in Washington, DC.

TAVR 52

TAVR Aortic valve Peripheral Arterial Disease Embolism 52

JAMA Cardiology

MAY 14, 2024

This cohort study examines whether there is an association between osteosarcopenia and adverse outcomes, such as increased risk of mortality, in older adults following transcatheter aortic valve replacement (TAVR).

Aortic valve 78

Aortic valve Aortic TAVR Outcomes 78

Frontiers in Cardiovascular Medicine

FEBRUARY 17, 2025

IntroductionSince TAVR was approved for lower-risk aortic stenosis (AS) patients, managing post-implantation conduction disturbances has become crucial, especially with self-expanding heart valves (SEV).

Pacemaker 52

Pacemaker Aortic Stenosis Aortic valve 52

Circulation: Cardiovascular Interventions

JANUARY 22, 2025

Some patients with aortic stenosis may require multiple valve interventions in their lifetime, and choosing transcatheter aortic valve replacement (TAVR) as the initial intervention may be appealing to many. If their transcatheter heart valve degenerates later in life, most will hope to undergo redo-TAVR.

TAVR 73

TAVR Aortic valve Aortic Stenosis 73

CardiacWire

JANUARY 31, 2024

Procedure trends certainly suggest that we’ve entered the TAVR era, but a pair of new studies show that surgical aortic valve replacement (SAVR) is a far better option for many younger and healthier patients who are increasingly seen as TAVR candidates.

TAVR 69

TAVR Aortic valve Bicuspid/Mitral Aortic 69

DAIC

APRIL 30, 2024

Tricuspid Valve Repair Existing literature on national surgical outcomes of isolated tricuspid valve repair or replacement is based on data from over a decade ago and may not reflect current practice results. Operative mortality and stroke were elevated in SAVR after TAVR patients with or without concomitant CABG at 9.3%

TAVR 111

TAVR Aortic valve Tricuspid Coronary Artery Bypass Graft 111

NEJM Journal Watch - Cardiology

FEBRUARY 22, 2024

Ten-year follow-up of an “all-comers” randomized trial demonstrates no difference in clinical outcomes between TAVR and SAVR.

Aortic valve 75

Aortic valve TAVR Outcomes Aortic 75

American College of Cardiology

FEBRUARY 12, 2024

The goal of the NOTION trial was to compare outcomes after transcatheter aortic valve replacement (TAVR) versus surgical aortic valve replacement (SAVR) in unselected patients with severe degenerative aortic stenosis.

Aortic valve 55

Aortic valve Aortic TAVR Stenosis 55

American College of Cardiology

NOVEMBER 5, 2024

What are outcomes among patients younger than 65 years who received transcatheter aortic valve replacement (TAVR) using a balloon-expandable valve compared to patients aged 65-80 years?

TAVR 52

TAVR Aortic valve Outcomes Aortic 52

Frontiers in Cardiovascular Medicine

DECEMBER 13, 2023

Transcatheter aortic valve replacement (TAVR) is a relatively new treatment method for aortic stenosis (AS) and has been demonstrated to be suitable for patients with varying risk levels.

Aortic valve 64

Aortic valve Cardiac Rehabilitation Aortic TAVR 64

American College of Cardiology

AUGUST 21, 2024

Among patients undergoing transcatheter aortic valve replacement (TAVR) with a balloon-expandable valve (BEV), what are the 3-year clinical outcomes associated with a small (20 mm) compared to a larger (≥23 mm) device, and is there a relationship between the discharge echocardiographic (echo) mean gradient (MG) and measured or predicted thresholds (..)

TAVR 52

TAVR Aortic valve Outcomes Aortic 52

American College of Cardiology

DECEMBER 4, 2024

Does measured or predicted prosthesis-patient mismatch (PPM) after transcatheter aortic valve replacement (TAVR) affect all-cause mortality at 2 years?

TAVR 49

TAVR Aortic valve Outcomes Aortic 49

American College of Cardiology

MARCH 6, 2024

What are the hemodynamic and clinical outcomes after transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) among patients with severe aortic stenosis (AS) and a small aortic annulus?

TAVR 59

TAVR Aortic Stenosis Aortic valve 59

American College of Cardiology

NOVEMBER 6, 2024

What are the contemporary characteristics, trends, and outcomes of intravascular lithotripsy (IVL)-assisted transfemoral (TF) transcatheter aortic valve replacement (TAVR) in the United States?

TAVR 45

TAVR Aortic valve Outcomes Aortic 45

American College of Cardiology

FEBRUARY 8, 2024

Is there a relationship between site-level volumes and outcomes for transcatheter aortic valve replacement (TAVR) and mitral transcatheter edge-to-edge repair (MTEER)?

TAVR 49

TAVR Aortic valve Outcomes Hospital 49

NEJM Journal Watch - Cardiology

APRIL 8, 2024

Another trial demonstrates substantial benefit with TAVR — at least for 1-year outcomes.

Aortic valve 75

Aortic valve TAVR Aortic Outcomes 75

Open Heart

APRIL 27, 2023

Background and aims Randomised controlled trials comparing transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) were performed in highly selected populations and data regarding long-term secondary complications beyond mortality are scarce.

Aortic valve 52

Aortic valve TAVR Aortic Outcomes 52

DAIC

JANUARY 29, 2024

These findings suggest opportunities to enhance clinical practice and improve outcomes for Medicare patients undergoing esophagectomy for cancer. Using the Society of Thoracic Surgeons Adult Cardiac Surgery Database , the study covers adult patients who underwent cardiac surgery after an initial TAVR from January 2012 to March 2023.

Research 111

Research TAVR Aortic valve Atrial Fibrillation 111

American College of Cardiology

NOVEMBER 6, 2024

In this week’s View, Dr. Eagle looks at the outcomes of balloon-expandable transcatheter aortic valve replacement (TAVR) in younger patients.

TAVR 52

TAVR Blood Pressure Aortic valve Aortic 52

American College of Cardiology

AUGUST 14, 2024

What is the relationship between diffusion-weighted magnetic resonance imaging (DW-MRI) total lesion number (TLN), individual lesion volume (ILV), and total lesion volume (TLV) with clinical stroke outcomes after transcatheter aortic valve replacement (TAVR)?

TAVR 52

TAVR Aortic valve Aortic Stroke 52

American College of Cardiology

OCTOBER 28, 2024

Two separate late-breaking clinical trials – EARLY TAVR and EVOLVED – presented at TCT 2024 explore whether early aortic valve intervention improves outcomes in patients with asymptomatic aortic stenosis (AS).

TAVR 52

TAVR Aortic valve Aortic Stenosis 52

Open Heart

JANUARY 31, 2022

Objectives To understand the patient and hospital level drivers of the variation in surgical versus trascatheter aortic valve replacement (SAVR vs TAVR) for patients with aortic stenosis (AS) and to explore whether this variation translates into differences in clinical outcomes.

Aortic valve 52

Aortic valve TAVR Aortic Outcomes 52

Open Heart

JUNE 21, 2022

However, the impact of elevated FP as detected by pretranscatheter aortic valve replacement (TAVR) echocardiogram on long-term outcomes after TAVR remains unclear. Objective To understand the impact of elevated FP in patients with severe AS who undergo TAVR. Patients with elevated FP had a mean age of 81.2±8.6

Aortic valve 52

Aortic valve TAVR Aortic AFIB 52

HCPLive

SEPTEMBER 20, 2024

As advancements in valvular technology progress, Nguyen highlights the need for long-term data and multidisciplinary collaboration to improve patient outcomes.

Aortic valve 64

Aortic valve TAVR Aortic Technology 64

Journal of the American Heart Association

FEBRUARY 14, 2025

BackgroundValveinvalve transcatheter aortic valve replacement (TAVR) is a recognized alternative for treating the structural valve deterioration of bioprosthetic valves. Recent guidelines and trials have expanded the indications for TAVR to include younger patients with structural valve deterioration.

Aortic valve 40

Aortic valve Aortic TAVR Outcomes 40

Frontiers in Cardiovascular Medicine

APRIL 7, 2024

Transcatheter aortic valve replacement (TAVR) has increasingly become a safe, feasible, and widely accepted alternative surgical treatment for patients with severe symptomatic aortic stenosis.

Aortic valve 52

Aortic valve Aortic TAVR Risk Factors 52

European Journal of Heart Failure

JANUARY 31, 2024

TAVR in heart failure. ABSTRACT Patients with severe aortic stenosis (AS) may develop heart failure (HF), the presence of which has traditionally been deemed as a final stage in AS progression with poor outcomes. The prognostic covariates and optimal timing of TAVR in patients with less than severe AS remain unclear.

Aortic valve 40

Aortic valve Heart Failure Aortic TAVR 40

American College of Cardiology

NOVEMBER 13, 2024

What are clinical outcomes among patients with severe aortic stenosis (AS) and coronary artery disease (CAD) undergoing surgical aortic valve replacement (SAVR) plus revascularization versus transcatheter aortic valve replacement (TAVR) plus percutaneous coronary intervention (PCI)?

Aortic valve 59

Aortic valve Coronary Artery Disease TAVR Aortic 59

Circulation: Cardiovascular Interventions

NOVEMBER 20, 2023

Transcatheter aortic valve replacement (TAVR) is increasingly being performed in younger and lower surgical risk patients. Reintervention for failed transcatheter heart valves will likely increase in the future as younger patients are expected to outlive the initial bioprosthesis.

Aortic valve 40

Aortic valve Aortic TAVR Heart Valves 40

The British Journal of Cardiology

FEBRUARY 20, 2024

Patients with bicuspid aortic valves (BAV) are predisposed to the development of aortic stenosis. We performed a pairwise meta-analysis, comparing the efficacy of transcatheter aortic valve replacement (TAVR) versus surgical aortic valve replacement (SAVR) in patients with BAV.

Aortic valve 40

Aortic valve Bicuspid/Mitral Aortic TAVR 40

American College of Cardiology

JANUARY 6, 2025

Subclinical leaflet thrombosis (SLT) has raised concerns about the long-term durability and outcomes of transcatheter aortic valve replacement (TAVR). Clinical valve thrombosis (CVT) is a rare complication after TAVR with an incidence of 0.62.8%

Thrombosis 40

Thrombosis TAVR Aortic valve Aortic 40

Circulation

NOVEMBER 11, 2024

Odds ratios (ORs) with 95% confidence intervals (CIs) for each study, employing a random-effects model for data synthesis irrespective of heterogeneity, were utilized as measures of outcomes. Seven studies showed that TAVR patients had a similar 1-year stroke risk to SAVR patients (OR 0.92, 95% CI 0.64 to 1.17, p=0.30, I2 3%).

Aortic valve 40

Aortic valve Aortic TAVR Stroke 40

Circulation: Cardiovascular Quality & Outcomes

DECEMBER 13, 2023

Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. The primary outcome was a composite of all-cause mortality or hospital readmission within 1 year. Below 5000 steps, the adjusted hazard ratio of composite outcome associated with each 1000-step count increase was 0.67 (0.50–0.89;P=0.007). years; 61% women).

TAVR 40

TAVR Aortic valve Aortic Outcomes 40

Coronary Artery Disease Journal

MAY 13, 2024

Objective To investigate the impact of prior coronary artery bypass grafting (CABG) and coronary lesion complexity on transcatheter aortic valve replacement (TAVR) outcomes for aortic stenosis. 23), which was not associated with better/worse clinical outcomes in patients with prior CABG.

Coronary Artery Bypass Graft 40

Coronary Artery Bypass Graft Aortic valve Aortic Stenosis 40